||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Omega Diagnostics Share Discussion Threads
Showing 1526 to 1549 of 1550 messages
|LOL Barry.This explains some of the recent trades, but it is clear too that our Mr Sneller doesn't like overpaying and has been picking up loose stock only as and when it comes available.But yes - it is good to have a fund manager continuously acquiring stock for his own personal account. Surprised it hasn't encouraged some other funds to think about taking a punt - but given the lowly market cap - perhaps it is not too unsurprising.|
|Yep - he's bought another 1.25m shares since November and is above 11% now.
Shame really. Without him I suspect we'd have been able to buy shedloads at 16p or even less :o((|
|Moves fast when it wants to....|
|Buyers will come...We just need the catalyst for them to see this as more than just a tired, low-growth med-tech stock. It will happen, but when, oh when.Come on ODX - strut your stuff.|
unfortunately mate there is only a handful of Investors that are prepared to buy at the moment, so when we have a seller we don't have sufficient buyers to take up the sells....but hopefully getting near to some news on the IDH situation and an update on the Indian plant and CD4....|
|Bought another 8k worth last couple days did not imagine getting them at this price again|
|Strange trading lately, now 2 x 500k trades showing late.......|
|Someone bought a nice chunk today at a pretty premium - hence the retrace on the bid price.ODX appear to have a large team out in Dubai for the medlab series event. HTTp://www.medlabseries.comHopefully plenty of sales developing for Allersys.|
|....are we on our way?The trading pattern has developed a very tight pennant over the last 3-6 months which mirror a larger pennant covering the last 3 years. We could easily see a break-out from here.|
|Thanks for that Rivaldo, not that surprising though bearing in mind that L&G hold 12.88% of ODX and have been onboard for over 6 years now, they must be as keen as we all are to see a bit of share action :o)|
|FYI, at Tuesday's Cenkos Growth Company Show, Richard Penny (senior fund manager at L&G UK Alpha Trust) noted ODX as one of his favoured investment ideas under the Medical Device category in his presentation.|
|a lot changing hands again.....|
|I am guessing that the 100k trade (just announce) filled at 17.63 is a buy.|
|Just been quoted 17.785p to sell 80k, so it looks like they are hunting for shares...|
|I was quoted 17.6 to sell in quantity this morning so given it was at 8:45 I think it was a sell.I agree with dibs though; looks well bid|
|I would think the 155k trade was a buy.....|
|I wonder if the delayed sell 155294@ 17.6 is the tale end of the offloading. Now that the IDH situation has been clarified it also frees our BoD, should they be in the mood, to fill their boots.|
|Yep def barry. What's puzzling me is the bid is up and large trade 155k for 17.6 but no sign of any buys?
Anyone got sight of L2? What's the order book look like? There must be a large one out there being filled? Sneller again?|
Thanks and yes I know the Enterprise grant was to help fund the expansion of the Allersys range which was a great help, but if IDH also help with the cost it will free up funds for the ongoing CD4 costs....just a thought....|
|Barry - the RNS 2.8.2016 stated:
"Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has secured a Scottish Enterprise research and development grant of £1.8 million. The R&D grant represents a significant contribution towards the total R&D project costs to fund the planned expansion of the Company's Allersys® range of reagent"
So this will cover a significant portion of the total cost. Perhaps the remainder will be covered by internal resources or a small part of a future fundraising?|
|My concern is more working capital. They need cash to finance CD4 roll-out when it happens and whilst the payback will be rapid, cash flow will be a problem.Anyway, going by his twitter feed, the sales director is still travelling extensively to far-flung parts of the world so I guess cash is not yet that tight!|
|Perhaps IDH will help fund the enlarged allergy tests as ODX were looking to increase from the 41 already CE marked to I think they stated 120..... as cash will be required for the expansion....|
|ODX do need cash and I wouldn't be surprised if a fundraising happens if the discussions with iDH don't involve any upfront cash.
I am sure the business can also support some debt now and as we are at a discount to NAV that may be a better option.|
|Might it mean cash needed if no injection from elsewhere?
It is a vote of confidence.|